Becton Dickinson Total Non-Operating Income/Expense 2010-2025 | BDX
Becton Dickinson annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Becton Dickinson total non-operating income/expense for the quarter ending March 31, 2025 was $-0.184B, a 82.18% increase year-over-year.
- Becton Dickinson total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.543B, a 27.17% increase year-over-year.
- Becton Dickinson annual total non-operating income/expense for 2024 was $-0.393B, a 12.47% decline from 2023.
- Becton Dickinson annual total non-operating income/expense for 2023 was $-0.449B, a 10.02% decline from 2022.
- Becton Dickinson annual total non-operating income/expense for 2022 was $-0.499B, a 10.73% decline from 2021.
Becton Dickinson Annual Total Non-Operating Income/Expense
(Millions of US $) |
| 2024 |
$-393 |
| 2023 |
$-449 |
| 2022 |
$-499 |
| 2021 |
$-559 |
| 2020 |
$-498 |
| 2019 |
$-584 |
| 2018 |
$-336 |
| 2017 |
$-546 |
| 2016 |
$-356 |
| 2015 |
$-335 |
| 2014 |
$-84 |
| 2013 |
$-89 |
| 2012 |
$-86 |
| 2011 |
$-48 |
| 2010 |
$-16 |
| 2009 |
$-11 |
Becton Dickinson Quarterly Total Non-Operating Income/Expense
(Millions of US $) |
| 2025-03-31 |
$-184 |
| 2024-12-31 |
$-148 |
| 2024-09-30 |
$-109 |
| 2024-06-30 |
$-102 |
| 2024-03-31 |
$-101 |
| 2023-12-31 |
$-81 |
| 2023-09-30 |
$-167 |
| 2023-06-30 |
$-78 |
| 2023-03-31 |
$-100 |
| 2022-12-31 |
$-104 |
| 2022-09-30 |
$-170 |
| 2022-06-30 |
$-115 |
| 2022-03-31 |
$-122 |
| 2021-12-31 |
$-92 |
| 2021-09-30 |
$-231 |
| 2021-06-30 |
$-114 |
| 2021-03-31 |
$-130 |
| 2020-12-31 |
$-84 |
| 2020-09-30 |
$-110 |
| 2020-06-30 |
$-110 |
| 2020-03-31 |
$-170 |
| 2019-12-31 |
$-108 |
| 2019-09-30 |
$-113 |
| 2019-06-30 |
$-165 |
| 2019-03-31 |
$-133 |
| 2018-12-31 |
$-173 |
| 2018-09-30 |
$-162 |
| 2018-06-30 |
$136 |
| 2018-03-31 |
$-180 |
| 2017-12-31 |
$-130 |
| 2017-09-30 |
$-162 |
| 2017-06-30 |
$-181 |
| 2017-03-31 |
$-84 |
| 2016-12-31 |
$-119 |
| 2016-09-30 |
$-88 |
| 2016-06-30 |
$-93 |
| 2016-03-31 |
$-90 |
| 2015-12-31 |
$-85 |
| 2015-09-30 |
$-105 |
| 2015-06-30 |
$-98 |
| 2015-03-31 |
$-68 |
| 2014-12-31 |
$-64 |
| 2014-09-30 |
$-24 |
| 2014-06-30 |
$-23 |
| 2014-03-31 |
$-18 |
| 2013-12-31 |
$-19 |
| 2013-09-30 |
$-16 |
| 2013-06-30 |
$-26 |
| 2013-03-31 |
$-21 |
| 2012-12-31 |
$-26 |
| 2012-09-30 |
$-27 |
| 2012-06-30 |
$-30 |
| 2012-03-31 |
$-14 |
| 2011-12-31 |
$-14 |
| 2011-09-30 |
$-19 |
| 2011-06-30 |
$-12 |
| 2011-03-31 |
$-12 |
| 2010-12-31 |
$-5 |
| 2010-09-30 |
$4 |
| 2010-06-30 |
$-10 |
| 2010-03-31 |
$-3 |
| 2009-12-31 |
$-7 |
| 2009-09-30 |
$-3 |
| 2009-06-30 |
$-3 |
| 2009-03-31 |
$-9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$51.094B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
